D'Incalci M - Search Results

1

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.

Belgiovine C, Bello E, Liguori M, Craparotta I, Mannarino L, Paracchini L, Beltrame L, Marchini S, Galmarini CM, Mantovani A, Frapolli R, Allavena P, D'Incalci M. Belgiovine C, et al. Br J Cancer. 2017 Aug 22;117(5):628-638. doi: 10.1038/bjc.2017.205. Epub 2017 Jul 6. Br J Cancer. 2017. PMID: 28683469 Free PMC article.

2

The unique interaction with immunity of FCE 24517, an antitumor drug with a novel mode of action.

Riganti F, Sironi M, Kankova M, D'Incalci M, Spreafico F, Mantovani A, Vecchi A. Riganti F, et al. Int J Immunopharmacol. 1992 Feb;14(2):239-51. doi: 10.1016/0192-0561(92)90036-k. Int J Immunopharmacol. 1992. PMID: 1624224

3

Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.

Damia G, Tagliabue G, Allavena P, D'Incalci M. Damia G, et al. Cancer Immunol Immunother. 1990;32(4):241-4. doi: 10.1007/BF01741707. Cancer Immunol Immunother. 1990. PMID: 2261598 Free PMC article.

4

In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells.

Allavena P, Pirovano P, Bonazzi C, Colombo N, Mantovani A, D'Incalci M. Allavena P, et al. J Natl Cancer Inst. 1990 Jan 17;82(2):139-42. doi: 10.1093/jnci/82.2.139. J Natl Cancer Inst. 1990. PMID: 2294223

5

Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.

Laudonio N, Zupi G, Erba E, Leonetti C, D'Incalci M. Laudonio N, et al. Br J Cancer. 1990 Mar;61(3):377-81. doi: 10.1038/bjc.1990.82. Br J Cancer. 1990. PMID: 2328201 Free PMC article.

6

DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate).

Broggini M, Hartley JA, Mattes WB, Ponti M, Kohn KW, D'Incalci M. Broggini M, et al. Br J Cancer. 1990 Feb;61(2):285-9. doi: 10.1038/bjc.1990.53. Br J Cancer. 1990. PMID: 2393411 Free PMC article.

7

Problems in the design of anticancer agents.

D'Incalci M, Balconi G, Broggini M, Colombo T, Marzola M, Morali F, Pang Y, Sen S, Spinelli L. D'Incalci M, et al. Cancer Surv. 1989;8(3):535-55. Cancer Surv. 1989. PMID: 2701084 Review.

8

Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy.

Massazza G, Tomasoni A, Lucchini V, Allavena P, Erba E, Colombo N, Mantovani A, D'Incalci M, Mangioni C, Giavazzi R. Massazza G, et al. Int J Cancer. 1989 Sep 15;44(3):494-500. doi: 10.1002/ijc.2910440320. Int J Cancer. 1989. PMID: 2777413

9

Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents.

Allavena P, Damia G, Colombo T, Maggioni D, D'Incalci M, Mantovani A. Allavena P, et al. Cell Immunol. 1989 Apr 15;120(1):250-8. doi: 10.1016/0008-8749(89)90192-5. Cell Immunol. 1989. PMID: 2784721

10

Flow cytometric analysis of DNA content in human ovarian cancers.

Erba E, Ubezio P, Pepe S, Vaghi M, Marsoni S, Torri W, Mangioni C, Landoni F, D'Incalci M. Erba E, et al. Br J Cancer. 1989 Jul;60(1):45-50. doi: 10.1038/bjc.1989.217. Br J Cancer. 1989. PMID: 2803914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters